Results 21 to 30 of about 130,544 (242)

Pseudomonas aeruginosa as an uncommon agent of infectious panniculitis [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2022
Pseudomonas aeruginosa is a Gram-negative bacillus that frequently causes septicemia, abscesses and infections in skin wounds. Panniculitis caused by this microorganism is unusual and there are few well-documented cases, none of them in a patient with ...
Tatiana Mina Yendo   +2 more
doaj   +1 more source

[Characteristics of the course of lupus erythematosus panniculitis in a retrospective analysis of 17 patients].

open access: yesOrvosi Hetilap, 2023
INTRODUCTION Lupus erythematous panniculitis (LEP) is a rare type of chronic cutaneous lupus erythematous. Clinical characteristics are tender, subcutaneous nodules, erythematous plaques.
Z. Király   +8 more
semanticscholar   +1 more source

Lupus Panniculitis: a rare bilateral and symmetrical manifestation of cutaneous Lupus Erythematosus in an adolescent girl

open access: yesDermatology Reports, 2022
Lupus panniculitis is included in the chronic cutaneous lupus erythematosus group. A 18-year-old female patient came with the complaint of lumps on her face.
Agnes Rosarina Prita Sari   +3 more
doaj   +1 more source

Centrifugal lipodystrophy on a spectrum with lupus erythematosus panniculitis in children and efficacy and safety of hydroxychloroquine: A clinicopathological study

open access: yesDermatologic Therapy, 2022
This study aimed to investigate the relationship between centrifugal lipodystrophy (CLD) and lupus erythematosus panniculitis (LEP), and the efficacy and safety of hydroxychloroquine (HCQ) for treating CLD in children.
Qianyue Xu   +7 more
semanticscholar   +1 more source

Pediatric-Onset Refractory Lupus Erythematosus Panniculitis Treated With Rituximab.

open access: yesCutis (New York, N.Y.), 2021
To the Editor: Lupus erythematosus panniculitis (LEP) is rare in the pediatric population. It can be difficult to manage, as patients may not respond to conventional treatments including hydroxychloroquine and prednisone.
Divya Angra   +3 more
semanticscholar   +1 more source

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE

open access: yesLupus Science and Medicine, 2023
Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific mucocutaneous manifestations in patients with systemic lupus ...
Jun Kang, Aaron Bao
doaj   +1 more source

Lupus Panniculitis in Association with Anti-Phospholipid Antibody Syndrome on a Background of Systemic Lupus Erythematosus: A Case Report and Literature Review

open access: yesEuropean Medical Journal Allergy & Immunology, 2020
Lupus panniculitis occurs in 1–3% of the patients diagnosed with systemic lupus erythematosus (SLE) and 10% of the patients diagnosed with discoid lupus erythematosus (DLE).
Abu Bakar Tauseef   +6 more
doaj   +1 more source

A rare case report of 32 years old female suffering from lupus panniculitis as an initial sign of systemic lupus erythematosus [PDF]

open access: yes, 2023
This case report describes a rare case of lupus panniculitis (LEP) in a 32-year-old Egyptian lady who did not have any history of chronic illness. The patient initially presented with leg pain, erythematous nodules, and back ulcers.
Barrouq, Deena M. Shaker   +1 more
core   +2 more sources

Cytophagic Histiocytic Panniculitis (CHP) in a Patient with SLE Found after Autopsy: When a Rash Is "Complicated!" [PDF]

open access: yes, 2019
Introduction: Cytophagic histolytic panniculitis (CHP) is a clinical disorder characterized by nodular panniculitis of the subcutaneous adipose tissue. It was first described in 1980 by Winkelmann.
Abbas, Hafsa   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy